Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
Anthony Tang(University of Pittsburgh Medical Center), Jean L. Rouleau(Montreal Heart Institute), Jeff S. Healey(Population Health Research Institute), David H. Birnie(University of Ottawa), George A. Wells(University of Ottawa), Graham Nichol(University of Washington), Robert S. Sheldon(University of Calgary), Raymond Yee(Western University), Malcolm Arnold(London Health Sciences Centre), Stuart J. Connolly(Population Health Research Institute), Mario Talajic(Montreal Heart Institute), John L. Sapp(Queen Elizabeth II Health Sciences Centre), Stefan H. Hohnloser(Goethe University Frankfurt)
Cited by 1,847
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Subclinical Atrial Fibrillation and the Risk of Stroke
|New England Journal of Medicine|2012|2.1k
Canadian Implantable Defibrillator Study (CIDS)
|Circulation|2000|1.6k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k